Skip to main content

Peer Review reports

From: HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study

Original Submission
3 Mar 2024 Submitted Original manuscript
19 Mar 2024 Reviewed Reviewer Report
23 Mar 2024 Reviewed Reviewer Report - Kazuto Tajiri
1 Apr 2024 Author responded Author comments - Shangkun Ning
2 Apr 2024 Reviewed Reviewer Report - Kazuto Tajiri
8 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 2
1 Apr 2024 Submitted Manuscript version 2
Publishing
8 Apr 2024 Editorially accepted
16 Apr 2024 Article published 10.1186/s12885-024-12233-6

You can find further information about peer review here.

Back to article page